Explore

Trendline Trendline
Symeres Enhances Spray Drying Capabilities at New Jersey Site for Drug Development

Symeres Enhances Spray Drying Capabilities at New Jersey Site for Drug Development

Symeres Enhances Spray Drying Capabilities at New Jersey Site for Drug Development
Trendline Trendline
Questex's Fierce Biotech Launches Event at London Life Sciences Week, Expanding Global Reach

Questex's Fierce Biotech Launches Event at London Life Sciences Week, Expanding Global Reach

Questex's Fierce Biotech Launches Event at London Life Sciences Week, Expanding Global Reach
Trendline Trendline
IGC Pharma Completes Enrollment for Phase 2 CALMA Trial Targeting Alzheimer's Agitation

IGC Pharma Completes Enrollment for Phase 2 CALMA Trial Targeting Alzheimer's Agitation

IGC Pharma Completes Enrollment for Phase 2 CALMA Trial Targeting Alzheimer's Agitation
Trendline Trendline
Questex's Fierce Biotech Launches Event at London Life Sciences Week, Expanding Global Presence

Questex's Fierce Biotech Launches Event at London Life Sciences Week, Expanding Global Presence

Questex's Fierce Biotech Launches Event at London Life Sciences Week, Expanding Global Presence
Trendline Trendline
Questex's Fierce Biotech Expands with Inaugural Event at London Life Sciences Week

Questex's Fierce Biotech Expands with Inaugural Event at London Life Sciences Week

Questex's Fierce Biotech Expands with Inaugural Event at London Life Sciences Week
Trendline Trendline
Antengene Receives IND Approval for ATG-201 in China for Autoimmune Disease Treatment

Antengene Receives IND Approval for ATG-201 in China for Autoimmune Disease Treatment

Antengene Receives IND Approval for ATG-201 in China for Autoimmune Disease Treatment
Trendline Trendline
Vistagen Achieves Key Safety Milestone in Fasedienol Clinical Program for Social Anxiety Disorder

Vistagen Achieves Key Safety Milestone in Fasedienol Clinical Program for Social Anxiety Disorder

Vistagen Achieves Key Safety Milestone in Fasedienol Clinical Program for Social Anxiety Disorder
Trendline Trendline
U.S. Polo Assn. Partners with Chestertons Polo in the Park for Third Year

U.S. Polo Assn. Partners with Chestertons Polo in the Park for Third Year

U.S. Polo Assn. Partners with Chestertons Polo in the Park for Third Year
Trendline Trendline
Seaport Therapeutics Reports Positive Phase 1 Data for GlyphAgo in Anxiety Treatment

Seaport Therapeutics Reports Positive Phase 1 Data for GlyphAgo in Anxiety Treatment

Seaport Therapeutics Reports Positive Phase 1 Data for GlyphAgo in Anxiety Treatment
Trendline Trendline
Syntis Bio Appoints Matt Dallas as Chief Financial Officer to Enhance Financial Strategy

Syntis Bio Appoints Matt Dallas as Chief Financial Officer to Enhance Financial Strategy

Syntis Bio Appoints Matt Dallas as Chief Financial Officer to Enhance Financial Strategy
Trendline Trendline
Harbour BioMed's HBM7004 IND Application Accepted by NMPA for Advanced Solid Tumors

Harbour BioMed's HBM7004 IND Application Accepted by NMPA for Advanced Solid Tumors

Harbour BioMed's HBM7004 IND Application Accepted by NMPA for Advanced Solid Tumors
Trendline Trendline
Harbour BioMed's IND Application for HBM7004 Accepted by China's NMPA

Harbour BioMed's IND Application for HBM7004 Accepted by China's NMPA

Harbour BioMed's IND Application for HBM7004 Accepted by China's NMPA